In advanced endometrial cancer, immunocheckpoint inhibitor-chemotherapy combination improves overall survival.

Published Date: 22 Mar 2024

It is recommended that dostarlimab and pembrolizumab regimens be implemented "as of yesterday.".

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

A three-quarters reduction in the risk of prostate cancer is associated with an annual increase in cardiorespiratory fitness of more than three percent.

2.

Top Options Are Discovered Through Direct Comparison of 25 Migraine Drugs.

3.

DNA's hidden shape reveals target to reverse ovarian cancer chemoresistance

4.

An inadvertent loss of weight may be an indication to consult a physician, according to research.

5.

In R/R Follicular Lymphoma, Tisa-Cel Produces Long-Lasting Responses.


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot